Skip to main content
Caplight Logo









Novelty Nobility Inc.

Novelty Nobility Inc.

Private
Seongnam-siHealthcare & Life Scienceshttps://www.noveltynobility.com/

Last Round

Series C

Nov 11, 2024

Est. Valuation

$89.74M

Total Funding Raised

$53.27M

Company Overview

Novelty Nobility Inc. is a biotechnology company that specializes in the design, discovery, and development of next-generation antibody therapeutics, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates for oncology and immunology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCmonoclonal antibodiesbispecific antibodiesantibody discoverybiotechdrug developmentoncology therapeuticsbiologicsretinal diseaselinker technologyclinical-stage biotechtherapeutic designdrug licensingbiotech pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novelty Nobility Inc. Comparables

Compare Novelty Nobility Inc. with similar companies based on industry and business-model similarity.

Novelty Nobility Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aimed Bio Inc.
86%
Pinotbio
84%
MabTics Co., Ltd.
82%

Novelty Nobility Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CNov 11, 2024
Series BMay 16, 2022
VC RoundMar 1, 2021
Series AJan 31, 2020

Key People

Founding team and executive leadership

Arlo McGinn

Chief Operating Officer

Executive Team

Novelty Nobility Inc. Investors

Notable investors and investment history

Novelty Nobility Inc. investors
InvestorRounds
KDB Capital CorpSeries C
K2 Investment PartnersVC Round
Shinhan Venture InvestmentSeries C, Series A
SL InvestmentSeries B, Series C
Ulmus InvestmentSeries A
QUAD Investment ManagementSeries A
NH Investment & SecuritiesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 10, 2024

    Grew 30% QoQ from 10 to 13 employees.

  • May 16, 2022

    $27M round with participation from NH Investment & Securities.

Novelty Nobility Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novelty Nobility Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novelty Nobility Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeongnam-si
Employee Range10
Year Founded2017
Last FundingNov 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?